D2L-SMO operates across a wide range of therapeutic areas spread across India, principally in Phase II and III trials. D2L’s continuously expanding geographic spread has empowered it with the extensive skill sets needed for handling clinical trials across all major therapeutic areas.

With an aim to ensure that all services offered by the D2L group have a seal of quality, reliability, consistency and excellence, we exercise utmost attention in selecting our researchers. We not only hand pick dedicated Investigators with access to large patient pools across therapeutic segments but also regularly monitor the standards maintained at these investigator sites.

D2L-SMO has an established presence in the ENT, Infectious Diseases, Diabetes segments with quality sites & varied patient pool available for trials. Also, with high prevalence of treatment naïve patients for Cancer and Arthritis in India, our trial sites in these segments are spread out from metros to the interior parts of the country. Currently D2L-SMO provides trial facilities for about 14 major therapeutic areas with new areas to be included shortly.

With D2L-SMO, be assured of the service quality and time bound research results, every time and in every segment